PROCEPT BioRobotics (PRCT) Cash from Investing Activities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Cash from Investing Activities data on file, last reported at -$2.9 million in Q1 2026.

• On a quarterly basis, Cash from Investing Activities fell 58.71% year-over-year to -$2.9 million in Q1 2026; TTM through Mar 2026 was -$10.4 million, a 142.71% decrease from a year earlier, with the FY2025 full-year figure at -$9.4 million, down 112.2% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$2.9 million, down from -$1.8 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for PRCT reached as high as -$55000.0 in Q1 2022 and fell as low as -$8.7 million in Q4 2023.
• Historically, Cash from Investing Activities has averaged -$2.6 million across 5 years, with a median of -$1.8 million in 2025.
• Across the five-year window, Cash from Investing Activities sank 9607.27% in 2023 and surged 95.74% in 2024, its largest moves.
• Year by year, Cash from Investing Activities stood at -$866000.0 in 2022, then slumped by 906.35% to -$8.7 million in 2023, then jumped by 86.53% to -$1.2 million in 2024, then tumbled by 57.58% to -$1.8 million in 2025, then tumbled by 57.51% to -$2.9 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$2.9 million in Q1 2026, -$1.8 million in Q4 2025, and -$2.9 million in Q3 2025.